CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 12.00
+2.00 (20.00%)
Apr 28, 2025, 3:35 PM GMT+1
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 3.27 million as of April 28, 2025. Its market cap has increased by 34.06% in one year.
Market Cap
3.27M
Enterprise Value
1.41M
Revenue
-31.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
12.00
Market Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 3.27M, a decrease of -88.43%. That is a compound annual growth rate of -10.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.24B |
| Haleon | 34.05B |
| Smith & Nephew | 8.68B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.19B |
| HUTCHMED (China) | 1.95B |
| Oxford Nanopore Technologies | 1.14B |